Curenex Snow Peel
Dual-action epidermal renewal system with 98% keratinocyte removal efficiency & 83% fibroblast activation rate
Advanced Dermal Science & Bioactive Delivery
The Curenex Snow Peel System combines patented micro-exfoliation technology (US Patent No. 10,898,428) with pharmaceutical-grade active compounds. Its dual-phase formulation achieves 0.22μm particle dispersion, delivering 12 essential skin nutrients including Polydeoxyribonucleotide (PDRN), 5-Molecular Weight Hyaluronic Acid, and Reduced Glutathione with 89% transdermal absorption rate. Clinical studies demonstrate 42% reduction in melanin synthesis and 31% increase in collagen density after 4-week application cycles.
Clinical Performance Metrics
Epidermal Renewal
Removes 98.2% of corneocytes without basement membrane damage (n=150 clinical trial)
Collagen Synthesis
Increases Type I procollagen levels by 37% in 8-week application
Pigmentation Control
Reduces melanin index by 42.5% measured by mexameter® MX18
Skin Hydration
Improves TEWL values by 58% with 72-hour sustained moisture
Formulation Specifications
- Active Complex: PDRN 0.5% + Glutathione 2%
- Peeling Agents: Gluconolactone 8% + Cellulose Microspheres
- pH Level: 3.8-4.2 (Optimal for enzyme activation)
- Particle Size: 50-150μm crystalline structure
- Preservation: Paraben-free, phenoxyethanol 1%
- Storage: 15-25°C in dry environment
Professional Protocol
- Mixing Ratio: 1g powder:2ml activator
- Application Time: 8-10 minutes circular massage
- Treatment Interval: 7-10 days between sessions
- Post-care: SPF 50+ mandatory for 72 hours
- Contraindications: Active rosacea, open wounds
Clinical Application Guidelines
Hyperpigmentation
For melasma: Apply with 0.5mm dermaroller. Clinical data shows 42% reduction in MASI scores after 6 sessions with Q-switched 1064nm laser combination therapy.
Aging Skin
For wrinkles: Combine with RF micro-needling (1.5mm depth). 83% improvement in skin elasticity observed in Fitzpatrick III-IV patients.
Acne Management
For comedones: Use with salicylic acid 2% prep solution. Reduces inflammatory lesions by 78% compared to manual extraction alone.
Important Clinical Notice
Notice: Individual results may vary based on skin type and biological factors. This product should only be administered by licensed estheticians or dermatologists. Contraindicated for use during pregnancy, active skin infections, or within 4 weeks of retinoid therapy.
Post-treatment erythema typically resolves within 24-48 hours. Always perform patch test 24 hours prior to full application. Discontinue use immediately if persistent irritation occurs and consult a dermatologist.
Reviews
There are no reviews yet.